Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cell therapy
Biotech
Arena BioWorks, 19 months after splashy launch, lays off staff
Arena BioWorks has laid off 30% of its workers 19 months after launching with $500 million and visions of bringing the Bell Labs model to biotech.
Nick Paul Taylor
Aug 22, 2025 10:05am
Cell therapy biotech keeps adapting, selling 4 programs for $55M
Jul 28, 2025 10:52am
Cell therapy biotech Adicet sheds 30% of staffers
Jul 24, 2025 10:20am
FDA rejects Capricor’s DMD cell therapy, asks for more data
Jul 11, 2025 9:18am
Minovia skates SPAC-wards into public market
Jun 25, 2025 10:33am
Industry disappointed as FDA reportedly puts Verdun on leave
Jun 20, 2025 1:53am
